Invest in

Biotech Breakthroughs

2.9%
0.8%
1.2%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
2.9%
0.8%
1.2%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for as low as $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
Open a Motif account to view and trade this basket of stocks:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
49.7% Research & Diagnostics 24.8%
14.1% Abbott Laboratories ABT 32.8%
9.0% 8xxxxx 8xxxxx 8xxxxxxxxx 8xxx 8xx 88.8%
8.3% 8xxxxxx 8xxxxxxxxxx 8xx 88.8%
4.4% 8xxxxxxxxx 8xxxxxxxxxx 8x 8xxxxxx 8xxxxx 8x 88.8%
3.7% 8xxxxxx 8xxxxxxxxxxx 8xx 8 88.8%
3.0% 8xxxx 8xxxxxxxxxx 8xxxxxxxxxxx 8xx 88.8%
2.8% 8xxxxxxxxxxxxx 8xxxxxxxxxxxx 8xxx 8xx 88.8%
2.3% 8xxxxxxxxxx 8xxx 8xx 88.8%
1.3% 8xxxxxx 8xxxxxxxxxx 8xxx 88.8%
0.9% 8xxxxx 8xxxxxxxxxx 8xx 88.8%
37.4% Mature Biotechnology 7.5%
14.8% Amgen Inc. AMGN 17.3%
9.9% Gilead Sciences Inc. GILD 9.2%
6.5% 8xxxxx 8xxx 8xxx 88.8%
6.2% 8xxxxxx 8xxxxxxxxxx 8xxx 88.8%
6.0% Other Biotech 37.4%
3.9% 8xxxx 8xx 8xxx 88.8%
1.0% 8xxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
1.0% 8xxxxxxx 8xx 8xxx 88.8%
4.0% Commercial Growth Biotech 22.8%
4.0% 8xxxxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
1.7% Early Commercial Biotech 24.2%
1.7% 8xxxxxxx 8xxxxxxxxxxxxx 8xxx 8xxx 88.8%
1.2% Development Stage Biotech 26.8%
1.2% 8xxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%

Quotes delayed 15 mins. Currently Aug 16, 2018 2:35:11 AM. Fields are marked with -- when data is unavailable.